Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software,...
Iterative Scopes’ $150 Million Series B Funding
Iterative Scopes’ $30 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneering company aiming to bring cutting-edge precision medicine to gastroenterology, closed a...